Televisit outpatient care feasible for inflammatory bowel disease

Televisit-delivered outpatient care for inflammatory bowel disease (IBD) is not associated with a higher risk for IBD-related hospitalization, according to a study published in the August issue of the American Journal of Gastroenterology.
Facebook Comments